The UK has become the first country in the world to approve the Pfizer/BioNTech COVID-19 vaccine for use.
It has been given the go-ahead by the health regulator MHRA and will be rolled out from early next week. Studies have shown the jab is 95% effective and works in all age groups. The government has secured 40 million doses of the vaccine, which needs to be refrigerated at -70C (-94F). Ten million doses are expected in the UK by the end of the year and patients need two each. Care home residents and their carers will be first in line to be vaccinated, the government’s Joint Committee on Vaccination and Immunisation (JCVI) has confirmed. Studies have shown the jab is 95% effective and works in all age groups. The government has secured 40 million doses of the vaccine, which needs to be refrigerated at -70C (-94F). Ten million doses are expected in the UK by the end of the year and patients need two each. Care home residents and their carers will be first in line to be vaccinated, the government’s Joint Committee on Vaccination and Immunisation (JCVI) has confirmed. Speaking to Sky News this morning, health secretary Matt Hancock said the approval of the vaccine is “fantastic news”. He added: “The MHRA – the fiercely independent regulator – has clinically authorised the vaccine for rollout. “The NHS stands ready to make that happen so from early next week we will start the programme of vaccinating people against COVID-19 here in this country. “As we know from earlier announcements, this vaccine is effective, the MHRA have approved it as clinically safe and we have a vaccine, so it’s very good news.”